ENTITY

Lexaria Bioscience (LEXX US)

17
Analysis
Health Care • Canada
Lexaria Bioscience Corp improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier ingestion methods. The Company's technology can be applied to ingestible product formats such as foods, beverages, oral suspensions, tablets, and capsules. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio.
more
bullish•Lexaria Bioscience
•08 Sep 2026 23:16

Primer: Lexaria Bioscience (LEXX US) - Sep 2026

Disruptive Proprietary Platform for High-Value Oral Peptide Delivery: Lexaria Bioscience Corp. (LEXX) utilizes its patented DehydraTECH...

Share
x